Private donations to enable global access to future COVID-19 vaccines


  • Heather Mason
  • Univadis Medical News
El acceso al contenido completo es sólo para profesionales sanitarios registrados. El acceso al contenido completo es sólo para profesionales sanitarios registrados.

Global Technology company TransferWise and an anonymous donor have made significant financial donations to the Vaccine Alliance Gavi’s advance market commitment for COVID-19 vaccines (Gavi COVAX AMC).

COVAX AMC is part of the Gavi-coordinated COVAX facility, which aims to provide guarantees to vaccine manufacturers, and incentivised investments in manufacturing capacity across a broad portfolio of vaccine candidates, managing the risk that most candidates will fail, and to enable equitable global access to a successful vaccine.

The new financial mechanism will support affordable access for developing countries and part of the broader COVAX facility aimed at securing global access to eventual COVID-19 vaccines. These commitments were made at an international pledging summit hosted by the European Commission and non-profit Global Citizen.

The additional funding will develop and universally deploy COVID vaccines, tests and treatments, supporting the work of the Access to COVID-19 tools (ACT) accelerator.

“Gavi's work to ensure future COVID-19 vaccines reach those in greatest need will be critical to ending this pandemic,” said Taavet Hinrikus, co-founder and chairman of TransferWise. “While we can’t offer health expertise, we can help make sure those working to find a vaccine get the maximum amount of money from supporters”.